Thakkar Roopal
SEC CIK 2004979 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | SVP, CMO, Gbl THERAPEUTICS | 52.4K | — | — | 7 | 2024-02-15 | 2026-02-27 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | Thakkar Roopal | EVP, CSO, R, D | F - Tax | $232.08 | -8,037 | 52.4K | -13% | -$1.87M | |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | Thakkar Roopal | EVP, CSO, R, D | A - Grant | $0.00 | +18.1K | 50.4K | +56% | $0 |
| 2025-03-04 | 2025-02-28 | ABBV | AbbVie | Thakkar Roopal | EVP, CSO, R, D | F - Tax | $205.02 | -4,678 | 42.3K | -10% | -$959.1K | |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | Thakkar Roopal | EVP, CSO, R, D | A - Grant | $0.00 | +10.6K | 47.0K | +29% | $0 |
| DMA | 2025-02-07 | 2024-02-15 | ABBV | AbbVie | Thakkar Roopal | EVP, CSO, R, D | A - Grant | $0.00 | +11.1K | 41.3K | +37% | $0 |
| 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Thakkar Roopal | SVP, CMO, Gbl THERAPEUTICS | F - Tax | $178.99 | -4,914 | 23.3K | -17% | -$879.6K | |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Thakkar Roopal | SVP, CMO, Gbl THERAPEUTICS | A - Grant | $0.00 | +17.8K | 20.5K | +649% | $0 |
Purchase Sale Sale after option exercise All abbreviations